Question 1

What specific information will be collected about my pregnancy and infant outcomes?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) clinical trial (NCT06433765). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my participation in this study help improve understanding of BRIUMVI®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) clinical trial (NCT06433765). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) clinical trial (NCT06433765). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I choose to withdraw from the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) clinical trial (NCT06433765). Contact the study team or your healthcare provider for specific answers.

Question 5

Will my healthcare provider be informed about my participation and its outcomes?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) clinical trial (NCT06433765). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my privacy be protected during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) clinical trial (NCT06433765). Contact the study team or your healthcare provider for specific answers.

What this study is about